Clinical trials
Phase 4 Dysbiosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acibadem Maslak Hospital | 1 |
| Albert Einstein College of Medicine | 1 |
| Boston Medical Center | 1 |
| Emory University | 1 |
| Kerry Murphy | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dysbiosis | 5 |
| Aging, Premature | 2 |
| Atrophic Vaginitis | 2 |
| HIV Infections | 2 |
| Surgical Wound Infection | 2 |
| Vaginitis | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Cystic Fibrosis | 1 |
| Reinfection | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.